Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT04745663
Other study ID # SW2019-3
Secondary ID 2019-001179-35
Status Terminated
Phase Phase 4
First received
Last updated
Start date February 8, 2021
Est. completion date April 30, 2021

Study information

Verified date September 2021
Source Norwegian University of Science and Technology
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Topical povidone-iodine (PI) is widely used as ocular antiseptic before and after surgery. The standard dose of 5% PI is however, associated with ocular irritation. We therefore want to test if a lower concentration of PI can be similarly efficacious in reducing bacterial growth while reducing ocular irritation.


Recruitment information / eligibility

Status Terminated
Enrollment 150
Est. completion date April 30, 2021
Est. primary completion date April 30, 2021
Accepts healthy volunteers No
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria: - Patients remitted to intravitreal injections at St. Olavs hospital. - Patients competent to give written consent Exclusion Criteria: - Infectious disease - Known epitheliopathy - Contact lens wear - Use of prescription ophthalmic medications - Diabetes

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Povidone-Iodine 0.3%
Low concentration iodine
Povidone-Iodine 5%
Standard concentration iodine

Locations

Country Name City State
Norway St Olavs Hospital Trondheim

Sponsors (2)

Lead Sponsor Collaborator
Norwegian University of Science and Technology St. Olavs Hospital

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Conjunctival bacterial culture Change in colony-forming units (CFU) per milliliter (ml) 1 hour. Bacterial sample is taken before and immediately after disinfection
Secondary Patient pain score Verbal numeric rating scale, from 0 to 10. During disinfection and after 1 hour when the anesthetic no longer is effective
Secondary Ocular staining score (OSS) Modified OSS using fluorescein dye 1 hour after disinfection
See also
  Status Clinical Trial Phase
Completed NCT03553017 - The EXPLORE Study - The Use of Binocular OCT Imaging for the Assessment of Ocular Disease
Completed NCT01739920 - Comparative Efficacy of Different Regimens of PVPI 5% Eye Drops Instillation in Reducing Conjunctival Bacterial Flora Phase 4
Completed NCT00575367 - Study of AzaSite Versus Vigamox in the Tears of Healthy Volunteers Phase 4
Not yet recruiting NCT03420820 - Concentrating on Antisepsis: 5% vs. 10% Povidone-Iodine Prior to Intravitreal Injection N/A
Unknown status NCT00335088 - Local Moxifloxacin and Povidone Iodine Versus Povidone Iodine Alone as a Prophylaxis Before Eye Operations Phase 3
Completed NCT00198523 - A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte Phase 3
Recruiting NCT01817478 - The Influence of Hospital Environment on Eyes Infections in Medical Staff N/A
Completed NCT00000130 - Endophthalmitis Vitrectomy Study (EVS) Phase 3
Completed NCT00564447 - Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers Phase 4
Completed NCT00575380 - Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery Phase 4
Recruiting NCT04075669 - Multiplex Strip Polymerase Chain Reaction for Diagnosis of Eye Infection Diseases From Corneal Scraping Samples